Thursday, October 28, 2021

White House says 400,000 people so far got boosters at pharmacies

Must read

Stock Markets48 minutes ago (Sep 28, 2021 01:25PM ET)

(C) Reuters. FILE PHOTO: A person receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19), at a mobile inoculation site in the Bronx borough of New York City, New York, U.S., August 18, 2021. REUTERS/David ‘Dee’ Delgado

By Ahmed Aboulenein and Susan Heavey

WASHINGTON (Reuters) -At least 400,000 people in the United States have received booster doses of the Pfizer/BioNTech COVID-19 vaccine after U.S. health regulators cleared the third round of shots for millions of people, and a million more are seeking them, the White House said on Tuesday.

The U.S. Centers for Disease Control and Prevention (CDC) last week backed an additional dose of the vaccine for people aged 65 and older, adults with underlying medical conditions that put them at risk for severe COVID-19 and adults in high-risk working and institutional settings.

“Just over this past weekend at pharmacies alone, over 400,000 Americans received the additional protection of a booster and almost 1 million people have already scheduled their booster shots through pharmacies over the coming weeks,” White House COVID-19 response coordinator Jeff Zients told reporters.

The United States had an average of 95,000 COVID-19 cases, 8,500 hospitalizations and more than 1,300 deaths in its most recent seven-day period, CDC Director Dr. Rochelle Walensky said at the same briefing.

Over 70 million eligible people remain unvaccinated, Walensky added, and only 30% of pregnant women have received the vaccine. Expecting mothers were included on the list of those eligible for boosters.

White House says 400,000 people so far got boosters at pharmacies

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Latest article

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.